United Therapeutics (UTHR) Tops Q3 EPS by 1.10, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 593.54 +7.06 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $586.48 | 52 Week High | $164.04 | |||
| Open | $591.76 | 52 Week Low | $97.52 | |||
| Day High | $599.45 | P/E | 108.51 | |||
| Day Low | $589.62 | EPS | $5.47 | |||
| Volume | 370,328 | |||||
